Maleic Acid
Electron Microscopy Sciences Maleic Acid, Crystalline, Repurified, A.C.S. 250 GR
(Toxilic Acid; cis-Butenediodic Acid)
CAS #110-16-7 HOOCCH:CHCOOH F.W. 116.08
Assay: 99.5%
Boiling point: 132-134°C
Apexbio Technology LLC Prasugrel hydrochloride 389574-19-0 10mM (in 1mL DMSO)
Prasugrel hydrochloride (CAS 389574-19-0) is a small molecule inhibitor that targets platelet activation by antagonizing the P2Y12 adenosine diphosphate (ADP) receptor on platelet surfaces By inhibiting this receptor prasugrel impedes ADP-mediated platelet aggregation a critical process in thrombus formation In biochemical assays prasugrel hydrochloride demonstrates an IC50 of 1 8 M for platelet inhibition This compound is utilized in biomedical research to investigate platelet signaling pathways and to model antithrombotic interventions in vitro
Medchemexpress LLC Maleic hydrazide | 123-33-1 | 99.98% | C4H4N2O2 | 1 ML
Maleic hydrazide (CAS: 123-33-1) is a systemic plant growth regulator and herbicide. It functions as an inhibitor of nucleic acid and protein synthesis, making it useful in agriculture despite its known mutagenic and clastogenic effects. This product is supplied as a 10 mM solution in 1 mL of DMSO, with a purity of 99.98%.
- Acts as a systemic plant growth regulator and herbicide
- Inhibits nucleic acid and protein synthesis
- Exhibits lower IC50 values for cell lines compared to Ethephon
- Shows least cytotoxicity on Vero cells, followed by Hep2 and HepG2 cells
- Has low acute toxicity by oral, dermal, and inhalation routes of exposure
Medchemexpress LLC Maleic hydrazide-d2 | 2398483-97-9 | 99.3% | C4H2D2N2O2 | 5 MG
Maleic hydrazide-d2 is a deuterium-labeled form of Maleic hydrazide, a systemic plant growth regulator and herbicide. It inhibits nucleic acid and protein synthesis and can be used as a tracer or internal standard for quantitative analysis in techniques such as NMR, GC-MS, or LC-MS.
- Can be used as a tracer
- Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
- Deuteration may impact pharmacokinetic and metabolic profiles of drugs
Apexbio Technology LLC Prasugrel hydrochloride 389574-19-0 5mg
Prasugrel hydrochloride (CAS 389574-19-0) is a small molecule inhibitor that targets platelet activation by antagonizing the P2Y12 adenosine diphosphate (ADP) receptor on platelet surfaces By inhibiting this receptor prasugrel impedes ADP-mediated platelet aggregation a critical process in thrombus formation In biochemical assays prasugrel hydrochloride demonstrates an IC50 of 1 8 M for platelet inhibition This compound is utilized in biomedical research to investigate platelet signaling pathways and to model antithrombotic interventions in vitro
Apexbio Technology LLC Prasugrel hydrochloride 389574-19-0 100mg
Prasugrel hydrochloride (CAS 389574-19-0) is a small molecule inhibitor that targets platelet activation by antagonizing the P2Y12 adenosine diphosphate (ADP) receptor on platelet surfaces By inhibiting this receptor prasugrel impedes ADP-mediated platelet aggregation a critical process in thrombus formation In biochemical assays prasugrel hydrochloride demonstrates an IC50 of 1 8 M for platelet inhibition This compound is utilized in biomedical research to investigate platelet signaling pathways and to model antithrombotic interventions in vitro
Sigma Aldrich Fine Chemicals Biosciences Maleic acid Standard for quantitative NMR, TraceCERT(R) | MFCD00063177 | 1G
Maleic acid Standard for quantitative NMR, TraceCERT(R) | Mol Wt: 116.07 | MFCD00063177 | 1G
Medchemexpress LLC Prasugrel | 150322-43-3 | MFCD09954140 | C20H20FNO3S | 1 ML
Prasugrel is a thienopyridine and proagent that inhibits platelet function. It is an orally active and potent P2Y12 receptor antagonist, inhibiting ADP-induced platelet aggregation.
- Inhibits platelet function
- Orally active
- Potent P2Y12 receptor antagonist
- Inhibits ADP-induced platelet aggregation
- For research use only
Medchemexpress LLC Benzonitrile, 5-[[4-[(6-chlorothieno[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl]methyl]-2-fluoro- | 866206-54-4 | C19H17ClFN5S | 25 MG
PRX-08066 is a selective and orally active 5-hydroxytryptamine receptor 2B (5-HT2BR) antagonist with a Ki of 3.4 nM. It inhibits the MAPK pathway, 5-HT release, and the expression of fibrotic factors. This compound also inhibits the proliferation of KRJ-I cells and induces apoptosis through caspase-3 activation. Additionally, it has been shown to inhibit pulmonary vascular remodeling and is considered for use in pulmonary arterial hypertension (PAH) and neuroendocrine tumors (NET).
- Selective and orally active 5-HT2BR antagonist
- Inhibits MAPK pathway and 5-HT release
- Inhibits expression of fibrotic factors (TGFβ1, CTGF, and FGF2)
- Inhibits proliferation of KRJ-I cells
- Induces apoptosis through caspase-3 activation
- Inhibits pulmonary vascular remodeling
- Potential for use in pulmonary arterial hypertension (PAH)
- Potential for use in neuroendocrine tumors (NET)
Teknova 0.5M Tris -Maleic Acid pH 5.0 Solution. 1000mL, Sterile. 2 pack.
0.5M Tris -Maleic Acid pH 5.0 Solution. 1000mL, Sterile. 2 pack.